Skip to main content

Table 2 Characteristics of the included studies

From: Efficacy of commercially available biological agents for the topical treatment of cervical intraepithelial neoplasia: a systematic review

 

First author, year of publication

Country

Study design

Topical agent

Diagnostic method

Number of patients (per protocol)

Disease

1

Sidhu, 1997 [14]

Ireland (UK)

RCT

5-FU

Biopsy

94

CIN 1–2

2

Rahangdale, 2014 [13]

USA

RCT

5-FU

Biopsy

55

CIN 2 (3)

3

Meyskens, 1994 [28]

USA

RCT

atRA

Biopsy

232

CIN 2–3

4

Ruffin, 2004 [29]

USA

RCT

atRA

Biopsy

174

CIN 2–3

5

Van Pachterbeke, 2009 [16]

Belgium

RCT

Cidofovir

Biopsy

48

CIN 2–3

6

Grimm, 2012 [30]

Austria

RCT

Imiquimod

Biopsy

55

CIN 2–3

  1. CIN cervical intraepithelial neoplasian, CT clinical trial, FU fluorouracil, HPV HPV infection, atRA all-trans retinoic acid, RCT randomized clinical trial, UK United Kingdom, USA United States of America